In ₹ Crore except Per Share Latest Annual | SURAKSHA FY26 | KRSNAA FY26 | HEALTHX FY26 | NEPHROPLUS FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 52.78× | ◆ 18.00× | 824.32× | 88.35× | 88.35× -40% | |
| P/B | 6.98× | 1.86× | ◆ 1.27× | 6.73× | 1.86× +274% | |
| EV/EBITDA | 17.79× | ◆ 11.01× | — | 32.18× | 21.59× -18% | |
| Market Cap | ₹1,699 Cr | ₹1,828 Cr | ₹970 Cr | ₹7,517 Cr | ₹1,828 Cr -7% | |
| Growth | ||||||
| Revenue CAGR 3Y | — | ◆ 16.63% | 8.26% | — | 12.45% | |
| Revenue CAGR 5Y | — | — | 19.20% | — | 19.20% | |
| Net Income CAGR 3Y | — | 17.76% | — | — | 17.76% | |
| Revenue YoY (latest Q) | 20.75% | 22.05% | ◆ 49.73% | — | 35.89% -42% | |
| Net Income YoY (latest Q) | ◆ 40.00% | -19.34% | -92.53% | — | -55.94% +172% | |
| Profitability | ||||||
| EBITDA Margin | ◆ 30.73% | 27.42% | -3.95% | 22.72% | 22.72% +35% | |
| Net Income Margin | 10.12% | ◆ 13.13% | -0.11% | 7.69% | 7.69% +32% | |
| Return on Common Equity | ◆ 13.22% | 10.35% | 0.15% | 6.88% | 6.88% +92% | |
| Return on Capital Employed | ◆ 13.89% | 7.84% | — | 11.63% | 9.73% +43% | |
| Return on Assets | ◆ 7.01% | 5.56% | -0.15% | 5.22% | 5.22% +34% | |
| Credit & Quality | ||||||
| Total Debt/Equity | ◆ 0.01× | 0.55× | — | 0.07× | 0.31× -97% | |
| Interest Coverage | ◆ 4.30× | 3.53× | -75.12× | 2.26× | 2.26× +90% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹310 Cr | ₹773 Cr | ₹1,319 Cr | ₹999 Cr | ₹999 Cr -69% | |
| Net Income | ₹31.4 Cr | ₹101 Cr | −₹1.4 Cr | ₹76.8 Cr | ₹76.8 Cr -59% | |
| Total Assets | ₹448 Cr | ₹1,824 Cr | ₹936 Cr | ₹1,471 Cr | ₹1,471 Cr -70% | |
| EPS | ₹6.18 | ₹31.3 | ₹0.37 | ₹8.48 | ₹8.48 -27% | |
| Book Value per Share | ₹46.75 | ₹302.23 | ₹240.57 | ₹111.27 | ₹240.57 -81% | |